Heart failure in East Asia

Current Cardiology Reviews

Volumn 9, Issue 2, 2013, Pages 112-122

  Guo, Yutao ^a,b   Lip, Gregory Y H ^b   Banerjee, Amitava ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

East Asia; Epidemiology; Heart failure; Management

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; IVABRADINE; ANGIOTENSIN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT;

ADVERSE OUTCOME; ARTICLE; ASIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CHINA; COMORBIDITY; DEVICE THERAPY; DIABETES MELLITUS; EAST ASIA; ECONOMIC DEVELOPMENT; ELDERLY CARE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART REHABILITATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; JAPAN; MORBIDITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGAPORE; TAIWAN; TELEMEDICINE; THAILAND; VALVULAR HEART DISEASE; AGE DISTRIBUTION; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; EPIDEMIOLOGY; REVIEW;

AGE DISTRIBUTION; ANGIOTENSIN RECEPTOR ANTAGONISTS; ASIA; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CAUSALITY; COMORBIDITY; CORONARY ARTERY DISEASE; FIBRINOLYTIC AGENTS; HEART FAILURE; HUMANS; INCIDENCE; PREVALENCE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TELEMEDICINE; TREATMENT OUTCOME;

EID: 84894387296     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X11309020004     Document Type: Article

References (60)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Asso-ciation Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
2. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol 2009; 53: 557-573.
3. National Clinical Guideline Centre (UK). Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update [Internet].London: Royal College of Physicians(UK);2010 Aug. http://www.ncbi.nlm.nih.gov/books/NBK65340/.
4. Norton C, Georgiopoulou VV, Kalogeropoulos AP, et al. Epidemi-ology and cost of advanced heart failure. Prog Cardiovasc Dis 2011; 54: 78-85.
5. Hu Shengshou, Kong Lingzhi editors, Report on cardiovascular diseases in China. 2012. National Center of Cardiovascular Diseases Encyclopdia of China Publishing House.
6. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124-1134.
7. Okura Y, Ramadan MM, Ohno Y, et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J. 2008; 72: 489-491.
8. Djoussé L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009; 302: 394-400.
9. Pei ZY, Zhao YS, Li JY, et al. Fifteen-year evolving trends of etiology and prognosis in hospitalized patients with heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 434-439.
10. Yin Q, Zhao Y, Li J, et al. The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing. Clin Cardiol 2011; 34: 442-446.
11. Yu SB, Cui HY, Qin M, et al. Characteristics of in-hospital patients with chronic heart failure in Hubei province from 2000 to 2010. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 549-552.
12. Liu H, Shi H, Yu J, et al. Obesity and chronic kidney disease in patients with chronic heart failure: an insight from the China Heart Survey. Clin Exp Nephrol 2011; 15: 522-528.
13. Yang YN, Ma YT, Liu F, et al. Incidence and distributing feature of chronic heart failure in adult population of Xinjiang. Zhonghua Xin Xue Guan Bing Za Zhi 2010; 38: 460-464.
14. Ma JP, Wang L, Dang Q, et al. Retrospective analysis of drug treatment on inpatients with chronic heart failure. Zhonghua Liu Xing Bing Xue Za Zhi 2007; 28: 78-82.
15. Tseng CH. Clinical features of heart failure hospitalization in younger and elderly patients in Taiwan. Eur J Clin Invest 2011; 41: 597-604.
16. Hung YT, Cheung NT, Ip S, et al. Epidemiology of heart failure in Hong Kong, 1997. Hong Kong Med J 2000; 6: 159-162.
17. Sanderson JE, Chan SK, Chan WW, et al. The aetiology of heart failure in the Chinese population of Hong Kong--a prospective study of 730 consecutive patients. Int J Cardiol 1995; 51: 29-35.
18. Chong AY, Rajaratnam R, Hussein NR, et al. Heart failure in a multiethnic population in Kuala Lumpur, Malaysia. Eur J Heart Fail 2003; 5: 569-574.
19. Ng TP, Niti M. Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998. Heart 2003; 89: 865-870.
20. Koseki Y, Watanabe J, Shinozaki T, et al. CHART Investigators. Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan. Circ J 2003; 67: 431-436.
21. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, et al. Characteristics and outcomes of patients with heart failure in general practices and hospitals. Circ J 2007; 71: 449-454.
22. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, et al. JCARE-CARD Investigators. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1893-1900.
23. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, et al. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1901-1908.
24. Shiba N, Shimokawa H. Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag 2008; 4: 103-113.
25. Shiba N, Nochioka K, Miura M, et al. Trend of westernization of etiology and clinical characteristics of heart failure patients in Ja-pan--first report from the CHART-2 study. Circ J 2011; 75: 823-833.
26. Hamaguchi S, Kinugawa S, Goto D, et al. JCARE-CARD Investigators. Predictors of long-term adverse outcomes in elderly patients over 80 years hospitalized with heart failure. - A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)-. Circ J 2011; 75: 2403-2410.
27. Hu Shengshou, Kong Lingzhi editors, Report on cardiovascular diseases in China. 2009. National Centre of Cardiovascular diseases Encyclopdia of China Publishing House.
28. Yancy CW, Fonarow GC, Albert NM, et al. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J 2009; 157: 754-762.e2.
29. Qian F, Ling FS, Deedwania P, et al. Get With The Guidelines Steering Committee and Investigators. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes 2012; 5: 126-133.
30. Kaul P, McAlister FA, Ezekowitz JA, et al. Ethnic differences in 1-year mortality among patients hospitalised with heart failure. Heart 2011; 97: 1048-1053.
31. Asanuma H, Kitakaze M. The largest cohort study opens a new era for the management of heart failure in Japan. Circ J 2011; 75: 775-776.
32. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
33. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
34. Swedberg K, Komajda M, Böhm M, et al. SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010; 376: 875-885.
35. Zannad F, McMurray JJ, Krum H, et al. EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011; 364: 11-21.
36. Cleland JG, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrom-botic strategies for patients with heart failure. Am Heart J 2004; 148: 157-164.
37. Massie BM, Collins JF, Ammon SE, et al. WATCH Trial Investigators. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009; 119: 1616-1624.
38. Cokkinos DV, Haralabopoulos GC, Kostis JB, Toutouzas PK; HELAS investigators. Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study. Eur J Heart Fail 2006; 8: 428-432.
39. Homma S, Thompson JL, Pullicino PM, et al. WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012; 366: 1859-1869.
40. Momomura SI, Tsutsui H, Sugawara Y, et al. For the MOMIJI Study Investigators. Clinical Efficacy of Cardiac Resynchroniza-tion Therapy With an Implantable Defibrillator in a Japanese Population. Circ J 2012; 76: 1911-1919.
41. Goto Y, Saito M, Iwasaka T, et al. Japanese Cardiac Rehabilitation Survey Investigators. Poor implementation of cardiac rehabilitation despite broad dissemination of coronary interventions for acute myocardial infarction in Japan: a nationwide survey. Circ J 2007; 71: 173-179.
42. Izawa KP, Oka K, Watanabe S, et al. Gender-related differences in clinical characteristics and physiological and psychosocial outcomes of Japanese patients at entry into phase II cardiac rehabilitation. J Rehabil Med 2008; 40: 225-230.
43. Otsu H, Moriyama M. Effectiveness of an educational self-management program for outpatients with chronic heart failure. Jpn J Nurs Sci 2011; 8(2): 140-152.
44. Kato N, Kinugawa K, Ito N, et al. Adherence to self-care behavior and factors related to this behavior among patients with heart failure in Japan. Heart Lung 2009; 38: 398-409.
45. Shen YQ, Jiang JF, Wang LM, et al. The effects of aerobic exercise on cardiac output during exercise in patients with chronic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 700-705.
46. Wang W, Chair SY, Thompson DR, et al. Effects of home-based rehabilitation on health-related quality of life and psychological status in Chinese patients recovering from acute myocardial infarction. Heart Lung 2012; 41: 15-25.
47. Chair SY, Chan SW, Thompson DR, et al. Short-term effect of motivational interviewing on clinical and psychological outcomes and health-related quality of life in cardiac rehabilitation patients with poor motivation in Hong Kong: a randomized controlled trial. Eur J Cardiovasc Prev Rehabil 2011.
48. Chan CL, Wang CW, Ho RT, et al. A systematic review of the effectiveness of qigong exercise in cardiac rehabilitation. Am J Chin Med 2012; 40: 255-267.
49. Hunt SA, Abraham WT, Chin MH, et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults.J Am Coll Cardiol 2009; 53(15): e1-e90.
50. Jenghua K, Jedsadayanmata A. Rate and predictors of early read-mission among Thai patients with heart failure. J Med Assoc Thai 2011; 94: 782-788.
51. Yu SB, Cui HY, Qin M, et al. The prognostic value of etiology in patients with chronic systolic heart failure. Zhonghua Liu Xing Bing Xue Za Zhi 2011; 32: 1148-1152.
52. Lee R, Chan SP, Chan YH, et al. Impact of race on morbidity and mortality in patients with congestive heart failure: a study of the multiracial population in Singapore. Int J Cardiol 2009; 134: 422-425.
53. Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, et al. Epidemiology of inicident heart failure in a contemporary elderly cohort: the health aging and body composition study. Arch Intern Med 2009; 169: 708-715.
54. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296: 2217-2226.
55. Loehr LR, Rosamond WD, Chang PP, et al. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 2008; 101: 1016-1022.
56. Butler J, Kalogeropoulos A. Worsening heart failure hospitalization epidemic we do not know how to prevent and we do not know how to treat! J Am Coll Cardiol 2008; 52: 435-7.
57. Gheorghiade M, Zannad F, Sopko G, et al. International Working Group on Acute Heart Failure Syndromes.Acute heart failure syndromes: current state and framework for future research. Circulation 2005; 112: 3958-3968.
58. Shiba N, Nochioka K, Kohno H, et al. Emerging problems of heart failure practice in Japanese women: lessons from the CHART study. Circ J 2008; 72: 2009-2014.
59. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S. Clinical characteristics and outcomes of heart failure with preserved ejection fraction: lessons from epidemiological studies. J Cardiol 2010; 55: 13-22.
60. West R, Liang L, Fonarow GC, et al. Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry. Eur J Heart Fail 2011; 13: 945-952.